Clinical Trials Browser

Phase 1 × milademetan × Other hematologic neoplasm × Clear all

NCT03671564 2023-11-07

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1 Completed

14 enrolled 14 charts

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute

NCT03552029 2022-05-20

Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)

Phase 1 Terminated

10 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute